GL1X · GenesisL1 explorer

MolNFT v1 · #137309 · protein

Crystal structure of Fab fragment of anti-CD22 epratuzumab

5VKK · Epratuzumab Fab heavy chain: “Crystal structure of Fab fragment of anti-CD22 epratuzumab”. X-ray diffraction, 8 pockets (best druggability 0.71). MolNFT v1 #137309 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5VKK
Type
protein
Length
871 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epratuzumab Fab heavy chain; Epratuzumab Fab light chain
UniProt
Q6N089, Q8TCD0
Pockets
8 · best druggability 0.71

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HEpratuzumab Fab heavy chainprotein2188% helix, 52% strandQ6N089
L, BEpratuzumab Fab light chainprotein2196% helix, 51% strandQ8TCD0
AEpratuzumab Fab heavy chainprotein2158% helix, 52% strandQ6N089

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110050.710.75120empty
23440.560.7547empty
31930.450.7428empty
4670.330.7514empty
5610.330.7616empty

Interfaces

4 interfaces between chains.

  • A–B · 1997 Ų buried · 15 hydrogen bonds · protein-protein
  • H–L · 1957 Ų buried · 15 hydrogen bonds · protein-protein
  • L–A · 248 Ų buried · 2 hydrogen bonds · protein-protein
  • L–B · 161 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 5VKK · Crystal structure of Fab fragment of anti-CD22 Epratuzumab · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.